导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 27.03% | 18/93 |
| 近一周 | -0.53% | 20/105 |
| 近一月 | -3.71% | 31/105 |
| 近一季 | -5.75% | 25/105 |
| 近半年 | 6.18% | 34/98 |
| 近一年 | 29.48% | 20/93 |
| 近两年 | 58.48% | 6/72 |
| 近三年 | 41.18% | 7/57 |
| 成立以来 | 64.61% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
15.25% 96/341 |
4.08% 192/349 |
12.15% 128/355 |
- - |
| 2024 | 23.19% 64/330 |
-2.86% 204/280 |
9.09% 33/310 |
19.47% 85/319 |
-2.70% 193/330 |
| 2023 | -10.89% 164/276 |
1.13% 132/205 |
-1.76% 132/230 |
-7.55% 207/262 |
-2.98% 209/276 |
| 2022 | -7.20% 32/202 |
-6.88% 47/153 |
5.65% 54/164 |
-16.40% 106/189 |
12.83% 73/202 |
| 2021 | -15.55% 80/151 |
4.52% 78/312 |
0.69% 213/328 |
-14.11% 260/358 |
-6.58% 91/151 |
| 2020 | -7.91% 66/104 |
-14.70% 190/280 |
4.13% 234/295 |
-6.76% 280/299 |
11.20% 106/305 |
| 2019 | 12.88% 61/89 |
10.15% 120/258 |
1.83% 119/268 |
-6.08% 235/253 |
7.17% 113/266 |
| 2018 | -8.54% 44/80 |
- - |
- - |
- - |
-7.43% 88/241 |
| 2017 | 30.25% 9/69 |
- - |
- - |
- - |
- - |
| 2016 | 9.83% 18/59 |
- - |
- - |
- - |
- - |
| 2015 | 1.61% 19/49 |
- - |
- - |
- - |
- - |
| 2014 | 3.99% 46/99 |
- - |
- - |
- - |
- - |
| 2013 | 1.40% 42/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2816 | 30.30% |
| 易方达标普生物科技美元汇A | 0.2448 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2415 | 28.01% |
| 易方达标普生物科技人民币A | 1.7298 | 27.30% |
| 易方达标普生物科技人民币C | 1.7060 | 27.21% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4679 | 19.43% |
| 广发生物科技指数美元(QDII)A | 0.2092 | 18.59% |
| 广发生物科技指数美元(QDII)C | 0.2058 | 18.41% |
| 广发生物科技指数人民币(QDII)A | 1.4780 | 17.80% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3491 | 17.75% |
| 华夏恒生ETF(QDII) VS. 华宝标普油气上游股票人民币A(162411) |